Related Experiment Video

Updated: Nov 28, 2025

Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

2.9K

COVID-19 pandemic and elderly: is the curtain dropped for urgent pacemaker implantations?

Massimiliano Marini1, Filippo Zilio2, Marta Martin2

  • 1Section of Cardiology, S. Chiara Hospital, Trento, Italy - massimiliano.marini@apss.tn.it.

Minerva Cardiology and Angiology
|December 1, 2020
PubMed

Insights

Urgent pacemaker implantations for bradyarrhythmia remained stable during the COVID-19 outbreak. Patient characteristics and outcomes showed no significant differences between 2019 and 2020, indicating consistent care.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Public Health

Background:

  • Permanent cardiac pacing is the standard treatment for severe symptomatic bradyarrhythmia.
  • The COVID-19 pandemic impacted healthcare, with reported decreases in acute coronary syndrome incidence.
  • Limited data exist on pacemaker implantation rates during the COVID-19 outbreak.

Purpose of the Study:

  • To analyze pacemaker implantation rates and patient characteristics during the COVID-19 outbreak.
  • To compare urgent pacemaker implantations in March-April 2020 versus the same period in 2019.

Main Methods:

  • Retrospective comparison of patients undergoing urgent pacemaker implantation.
  • Group I: March-April 2019; Group II: March-April 2020.
  • Analysis of patient numbers, characteristics, indications, and outcomes.

Main Results:

  • 34 pacemaker implantations in 2020 (Group II) vs. 27 in 2019 (Group I).
  • Similar baseline characteristics, pacemaker types (approx. 50% dual-chamber), and indications (advanced atrio-ventricular block).
  • No significant differences in procedural complications or in-hospital/1-month mortality.

Conclusions:

  • Urgent pacemaker implantations for symptomatic bradyarrhythmia were maintained during the COVID-19 outbreak.
  • Healthcare services for bradyarrhythmia were not significantly disrupted.
  • Consistent patient management and outcomes were observed despite the pandemic.
Abstract

More Related Videos

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

390
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

2.9K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
141
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
145
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
417
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
104
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
182
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
204